In March 2016, as compared to March 2015, Unit Sales* rose 18.3% in Connecticut, 20.9% in New York**, 9.3% in Manhattan, 17.5% in Brooklyn, 14.6% in Rhode Island, 13.7% in Vermont and 21.6% in New Hampshire. Meanwhile, Sales to List Price rose 0.6% in Massachusetts and 1.1% in Maine.
What comes to mind when you think of Vermont? Chilly weather? Skiing? Maple Syrup? While Vermont is widely known for its abundance of winter activities, it’s also packed with tons of things to do in the summer.
It’s hard to believe summer is just around the corner! Warmer weather and longer days make for the perfect time to escape from the daily grind and hit the beach. Before you start planning your next trip overseas or across the country, why not check out what’s in your backyard? There are plenty of opportunities to explore nearby towns and get to know the locals.
It’s spring! The birds chirping, flowers are blooming, the sun is out – and so are prospective home buyers. They’re on the go and ready to look into a place to call home. But, is your home ready?
Company Hosts Fourth Convention at the Mohegan Sun CasinoWilliam Raveis Real Estate, Mortgage & Insurance’s fourth convention highlighted innovations and accomplishments over their 42-year history
In February 2016, as compared to February 2015, Unit Sales* rose 19.3% in Connecticut, 26.2% in New York**, 28.3% in Manhattan, 11.3% in Brooklyn, 5.5% in Rhode Island, 20.7% in Vermont and 24.5% in New Hampshire. Meanwhile, Sales to List Price rose 0.7% in Massachusetts and 2.8% in Maine.
We’re proud to recognize the outstanding real estate sales associates who joined our team in March. With more than 3,800 sales associates in 120 offices, we take pride in focusing on each individual as a part of our team, and we’re thrilled these individuals joined us this past month.
SHELTON, Conn.–In Summer 2015, William Raveis Real Estate, Mortgage & Insurance hosted their first annual fundraising event to benefit the Damon Runyon Cancer Research Foundation. The Raveis Ride + Walk raised over $500,000 for cancer research.